The curcumin analog DM-1 inhibits migration and downregulates MMP-2 in vemurafenib resistant melanoma cell lines (2016)
- Authors:
- Autor USP: ENGLER, SILVYA STUCHI MARIA - FCF
- Unidade: FCF
- Assunto: MELANOMA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 52, suppl. 1, p. 40 res. FCF076, 2016
- Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
SOUZA, Nayane de; OLIVEIRA, Érica Aparecida de; FAIÃO-FLORES, Fernanda; MARIA-ENGLER, Silvya Stuchi. The curcumin analog DM-1 inhibits migration and downregulates MMP-2 in vemurafenib resistant melanoma cell lines. Brazilian Journal of Pharmaceutical Sciences[S.l: s.n.], 2016. -
APA
Souza, N. de, Oliveira, É. A. de, Faião-Flores, F., & Maria-Engler, S. S. (2016). The curcumin analog DM-1 inhibits migration and downregulates MMP-2 in vemurafenib resistant melanoma cell lines. Brazilian Journal of Pharmaceutical Sciences. São Paulo. -
NLM
Souza N de, Oliveira ÉA de, Faião-Flores F, Maria-Engler SS. The curcumin analog DM-1 inhibits migration and downregulates MMP-2 in vemurafenib resistant melanoma cell lines. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 40 res. FCF076. -
Vancouver
Souza N de, Oliveira ÉA de, Faião-Flores F, Maria-Engler SS. The curcumin analog DM-1 inhibits migration and downregulates MMP-2 in vemurafenib resistant melanoma cell lines. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 40 res. FCF076. - Avaliação da citotoxicidade de compostos anti-glicação em células de pele humanas
- Exhaustion of autophagy-mediated cell survival underlies the pre-clinical and clinical activity of chemotherapy combined with the AKT inhibitor MK-2206 in BRAF wild-type melanoma
- The combination of intermittent treatment of vemurafenib and DM-1 compound for melanoma therapies
- Epiderme equivalente para estudos de fotoproteção in vitro
- REPIN-1 as a tumoral marker in cervical cancer
- ADK inhibitor is a potent antiproliferative agent in naïve and resistant to BRAF inhibitor human melanomas
- SIN3B: possible role in melanoma resistance and progression
- Inhibition of proliferation and invasion in 2D and 3D models by 2-methoxyestradiol in human melanoma cells
- Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation
- Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
